Artelo Biosciences (ARTL) Operating Leases (2021 - 2025)
Artelo Biosciences (ARTL) posted quarterly Operating Leases of $29000.0 for Q4 2025, down 57.97% year-over-year from $69000.0 in Q4 2024, and down 27.5% quarter-over-quarter from $40000.0 in Q3 2025.
Artelo Biosciences (ARTL) Operating Leases (2021 - 2025) Analysis & Trends
Artelo Biosciences (ARTL) has reported Operating Leases for 5 consecutive years, with $29000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Operating Leases fell 57.97% year-over-year to $29000.0; the TTM figure through Dec 2025 stood at $29000.0 (down 57.97% YoY), while the FY2025 annual figure was $29000.0, down 57.97% from the prior year.
- Operating Leases eased to $29000.0 in Q4 2025 per ARTL's latest filing, from $40000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $96000.0 in Q1 2024 and bottomed at $6000.0 in Q2 2023.
- Historically, Operating Leases has averaged $50066.7 across 5 years, with a median of $51000.0 in 2025.
- Annual changes were most pronounced in 2023 — Operating Leases slumped 85.0% — and 2024, when it soared 1350.0%.
- Artelo Biosciences' Operating Leases stood at $59000.0 in 2021, then tumbled by 61.02% to $23000.0 in 2022, then slumped by 73.91% to $6000.0 in 2023, then surged by 1050.0% to $69000.0 in 2024, then slumped by 57.97% to $29000.0 in 2025.
- Business Quant data shows ARTL's Operating Leases at $29000.0 in Q4 2025, $40000.0 in Q3 2025, and $51000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Artelo Biosciences | 111,698.23 | -488,301.77 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 29,000.00 |
| Sep 30, 2025 | 40,000.00 |
| Jun 30, 2025 | 51,000.00 |
| Mar 31, 2025 | 59,000.00 |
| Dec 31, 2024 | 69,000.00 |
| Sep 30, 2024 | 78,000.00 |
| Jun 30, 2024 | 87,000.00 |
| Mar 31, 2024 | 96,000.00 |
| Jun 30, 2023 | 6,000.00 |
| Mar 31, 2023 | 15,000.00 |
| Dec 31, 2022 | 23,000.00 |
| Sep 30, 2022 | 32,000.00 |
| Jun 30, 2022 | 40,000.00 |
| Nov 30, 2021 | 59,000.00 |
| Aug 31, 2021 | 67,000.00 |